Ralf Nauen
Ralf Nauen
Bayer CropScience Aktiengesellschaft
BCS AG-R-I-BI-PPS-RM
Monheim
Germany
40789
Papers:
0931
Toxicodynamic consequences of selected target site mutations and implications for resistance management